<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04834414</url>
  </required_header>
  <id_info>
    <org_study_id>CHIPS</org_study_id>
    <secondary_id>W81XWH2090021</secondary_id>
    <nct_id>NCT04834414</nct_id>
  </id_info>
  <brief_title>CHIlled Platelet Study &quot;CHIPS&quot;</brief_title>
  <acronym>CHIPS</acronym>
  <official_title>CHIlled Platelet Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philip Spinella</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A phase 3 randomized partial blind storage duration ranging study in patients undergoing&#xD;
      complex cardiac surgery that will compare the transfusion of cold stored platelets to&#xD;
      standard room temperature stored platelets. The primary objective is to establish that cold&#xD;
      stored platelets have a non-inferiority (or superiority) to room temperature platelets.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 21, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2024</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>Adaptive Design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Partial Blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Hemostatic efficacy</measure>
    <time_frame>24 hours after first study platelet transfusion</time_frame>
    <description>Assessed by a bleeding score, a modified Peri-Operative bleeding score: the score ranges from 1-5. A lower score signifies a better outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chest tube output</measure>
    <time_frame>24 hours from first study platelet transfusion or ICU admit (determined from which occurs last)</time_frame>
    <description>Assessed by volume</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Blood product administration</measure>
    <time_frame>24 and 72 hours from start time of first study platelet transfusion</time_frame>
    <description>The quantity of RBCs, Plasma, Platelets, Cryoprecipitate, and Whole blood</description>
  </other_outcome>
  <other_outcome>
    <measure>Total Dose of individual hemostatic adjuncts</measure>
    <time_frame>24 and 72 hours from start time of first study platelet transfusion</time_frame>
    <description>Antifibrinolytic and coagulation factor concentrates</description>
  </other_outcome>
  <other_outcome>
    <measure>Mechanical ventilation</measure>
    <time_frame>up to 28 days after first study platelet transfusion</time_frame>
    <description>Duration of mechanical ventilation days</description>
  </other_outcome>
  <other_outcome>
    <measure>Length of stay</measure>
    <time_frame>up to 28 days</time_frame>
    <description>ICU and hospital length of stay</description>
  </other_outcome>
  <other_outcome>
    <measure>Relative change in hemostatic parameters</measure>
    <time_frame>6 and 24 hours after first study platelet transfusion</time_frame>
    <description>CBC (platelet count and hemoglobin), PT/INR, PTT, fibrinogen, and TEG</description>
  </other_outcome>
  <other_outcome>
    <measure>Unplanned sternal closure delay</measure>
    <time_frame>prior to ICU admission</time_frame>
    <description>Sternum left open after cardiac surgery</description>
  </other_outcome>
  <other_outcome>
    <measure>Re-exploration for bleeding</measure>
    <time_frame>24 hours first study platelet transfusion</time_frame>
    <description>Return to OR after ICU admission</description>
  </other_outcome>
  <other_outcome>
    <measure>Unplanned extracorporeal support post operatively</measure>
    <time_frame>within 48 hours of first study platelet transfusion</time_frame>
    <description>Placed on ECMO</description>
  </other_outcome>
  <other_outcome>
    <measure>Morbidities after ICU admission</measure>
    <time_frame>within 7 days of first study platelet transfusion</time_frame>
    <description>Acute respiratory distress syndrome, need for and duration of renal support, renal failure, septic shock</description>
  </other_outcome>
  <other_outcome>
    <measure>Measures of end organ injury</measure>
    <time_frame>within 48 hours of first study platelet transfusion</time_frame>
    <description>If BUN, creatinine, lactate, troponin, alanine aminotransferase (ALT) are collected clinically.</description>
  </other_outcome>
  <other_outcome>
    <measure>Transfusion associated adverse events</measure>
    <time_frame>within 7 days of first study platelet transfusion</time_frame>
    <description>As per CDC guidelines</description>
  </other_outcome>
  <other_outcome>
    <measure>Arterial thrombotic event</measure>
    <time_frame>within 7 days of first study platelet transfusion</time_frame>
    <description>Stroke, MI</description>
  </other_outcome>
  <other_outcome>
    <measure>Venous thrombotic event</measure>
    <time_frame>within 7 days of first study platelet transfusion</time_frame>
    <description>Deep vein thrombosis or pulmonary embolism confirmed by ultrasound, venography, perfusion scan, spiral CT, MRI, or pulmonary angiogram</description>
  </other_outcome>
  <other_outcome>
    <measure>All cause mortality</measure>
    <time_frame>up to 28 days</time_frame>
    <description>Death for any reason</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Acute Blood Loss</condition>
  <arm_group>
    <arm_group_label>Room Temperature Platelets</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Platelets stored at 20-24 degrees Celsius</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cold Stored Platelets</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Platelets stored at 1-6 degree Celsius</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Cold Stored Platelets</intervention_name>
    <description>Platelets stored at 1-6 degree Celsius</description>
    <arm_group_label>Cold Stored Platelets</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Room Temperature Platelets</intervention_name>
    <description>Platelets stored at 20-24 degrees Celsius</description>
    <arm_group_label>Room Temperature Platelets</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age greater than 28 days and less than 85 years&#xD;
&#xD;
          -  Planned complex cardiac surgery with planned use of cardiopulmonary bypass&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Expected order for washed or volume reduced platelets&#xD;
&#xD;
          -  Patient with known anti-platelet antibodies&#xD;
&#xD;
          -  Platelet transfusion refractoriness due to anti-HLA antibodies&#xD;
&#xD;
          -  Known or suspected pregnancy&#xD;
&#xD;
          -  Previously randomized in this study&#xD;
&#xD;
          -  Conscious objection or unwillingness to receive blood products&#xD;
&#xD;
          -  Known IgA deficiency&#xD;
&#xD;
          -  Known congenital platelet disorder&#xD;
&#xD;
          -  Known congenital bleeding disorder&#xD;
&#xD;
          -  Planned post-operative extracorporeal membrane oxygenation (ECMO), ventricular assist&#xD;
             device (VAD), and/or continuous renal replacement therapy (CRRT)/ hemodialysis&#xD;
&#xD;
          -  Patients intended to receive whole blood either intra-operative or post-operative for&#xD;
             bleeding&#xD;
&#xD;
          -  Platelet transfusion (of any type) within 24 hours prior to the date of surgery&#xD;
&#xD;
          -  Pre-operative thrombocytopenia, defined as platelet count &lt;75x10(9)/L, based on the&#xD;
             most recent labs completed within 72 hours prior to the date of surgery.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>84 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip C Spinella, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie E Steiner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicole D Zantek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Meghan Huff, BSN</last_name>
    <phone>314-362-1319</phone>
    <email>meghanhuff@wustl.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christina Daniel, BSN</last_name>
    <email>christina.daniel@wustl.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clnic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Montonye</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baylor Texas Children's</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Menard Elizabeth</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Krachey E, Viele K, Spinella PC, Steiner ME, Zantek ND, Lewis RJ. The design of an adaptive clinical trial to evaluate the efficacy of platelets stored at low temperature in surgical patients. J Trauma Acute Care Surg. 2018 Jun;84(6S Suppl 1):S41-S46. doi: 10.1097/TA.0000000000001876.</citation>
    <PMID>29521797</PMID>
  </reference>
  <reference>
    <citation>Strandenes G, Sivertsen J, Bjerkvig CK, Fosse TK, Cap AP, Del Junco DJ, Kristoffersen EK, Haaverstad R, Kvalheim V, Braathen H, Lunde THF, Hervig T, Hufthammer KO, Spinella PC, Apelseth TO. A Pilot Trial of Platelets Stored Cold versus at Room Temperature for Complex Cardiothoracic Surgery. Anesthesiology. 2020 Dec 1;133(6):1173-1183. doi: 10.1097/ALN.0000000000003550.</citation>
    <PMID>32902572</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 31, 2021</study_first_submitted>
  <study_first_submitted_qc>April 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 8, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Philip Spinella</investigator_full_name>
    <investigator_title>Professor- Surgery and Critical Care Medicine, Co- Director- Trauma and Transfusion Medicine Research Center, Associate Medical Director- Center for Military Medicine Research</investigator_title>
  </responsible_party>
  <keyword>platelets</keyword>
  <keyword>cold-stored platelets</keyword>
  <keyword>bleeding</keyword>
  <keyword>hemostasis</keyword>
  <keyword>complex cardiac surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

